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INTRODUCTION 
 
Sixteen states and the District of Columbia have now legalized 
medical marijuana.1  According to recent polls, popular support for 
medical marijuana hovers around 75 percent in the United States.2  As 
of 2008, an estimated 270,000 Americans were using medical mari-
juana.3  Despite those facts, medical marijuana use is prohibited by 
the federal Controlled Substances Act (CSA), and users risk criminal 
prosecution.4  Undoubtedly, many medical marijuana users are also 
employees who risk being fired for their choice of treatment.  State 
laws have provided a step forward, but one that is fraught with uncer-
tainty.       
Joseph Casias, a twenty-nine year old father of two, suffers from 
inoperable sinus and brain cancer.5  Casias formerly worked for Wal-
mart in Battle Creek, Michigan, earning about $27,000 a year, and he 
has incurred substantial debt from his medical bills.6  In 2008, Casias 
was named Associate of the Year.7  His doctor prescribed medical 
marijuana, which is legal in Michigan, to treat pain that more tradi-
tional drugs could not alleviate.8  Casias never used marijuana at 
work, nor did he come to work under the influence.9  Following a 
  
 1 Alaska, Arizona, California, Colorado, District of Columbia, Delaware, 
Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, 
Rhode Island, Vermont, Washington. 16 Legal Medical Marijuana States and DC: 
Laws, Fees, and Possession Limits, PROCON.ORG, 
http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881 (last 
updated Sept. 19, 2011). 
 2 See THE PEW RESEARCH CENTER FOR THE PEOPLE & THE PRESS, MODEST 
RISE IN PERCENTAGE FAVORING GENERAL LEGALIZATION: BROAD PUBLIC SUPPORT FOR 
LEGALIZING MEDICAL MARIJUANA (Apr. 1, 2010), http://people-
press.org/report/602/marijuana; Washington Post-ABC News Poll, 
WASHINGTONPOST.COM, http://www.washingtonpost.com/wp-
srv/politics/polls/postpoll_011610.html (last visited Mar. 14, 2011); Peter Hart & 
William McInturff, NBC NEWS/WALL STREET JOURNAL SURVEY 23 (Oct. 2009), 
available at http://online.wsj.com/public/resources/documents/wsjnbc-10272009.pdf.     
 3 How Many People in the U.S. Use Medical Marijuana?, PROCON.ORG, 
http://medicalmarijuana.procon.org/view.answers.php?questionID=001199 (last up-
dated Mar. 11, 2009).  
 4 21 U.S.C. § 812(c)(c)(10) (2006); 21 C.F.R. § 1308.11 (2011); Gonzales 
v. Raich, 545 U.S. 1, 7-9 (2005). 
 5 Eve Tahmincioglu, Wal-Mart Worker Fired over Medical Marijuana, 
MSNBC.COM (Mar. 17, 2010), http://www.msnbc.msn.com/id/35913492/ns/business-
careers. 
 6 Id. 
 7 Id. 
 8 Id. 
 9 Id. 
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work-related injury, Walmart required a drug test, which revealed 
Casias’s marijuana use.10  Casias explained that he was using mari-
juana for medical purposes and presented his Michigan marijuana 
registry card to Walmart.  Walmart fired Casias.11 
Jane Roe lives in Bremerton, Washington, with her children and 
has suffered from debilitating migraines for years.  Her migraines 
cause chronic pain, nausea, blurred vision, and light sensitivity.12  
After other treatments proved inadequate, her doctor prescribed medi-
cal marijuana, which is legal in Washington.13  In 2006, Roe was hired 
by Teletech Customer Care Management for a phone and email cus-
tomer service position.14  Teletech tests all new hires for illegal drugs, 
and Roe informed Teletech that she was using medical marijuana and 
offered to provide documentation.15  Roe took the drug test, began 
work, and Teletech fired her a week later when they received the re-
sults of her drug test.16 
Casias and Roe should not have to choose between effective 
treatment and gainful employment.  Medical marijuana alleviates the 
debilitating symptoms of their illnesses.  It gives them the ability to 
work and support their families.  It enables them to be productive and 
self-sufficient.  On the other hand, employers have a legitimate inter-
est in workplace safety and productivity.  The side effects of mari-
juana could create unacceptable risks in certain instances (e.g., airline 
pilots or structural steel workers).  But, the interests of both employers 
and employees ought to be considered before employment decisions 
are made.  An inflexible prohibition of medical marijuana short-
circuits an important balancing process and tramples the rights of dis-
abled employees for whom marijuana is an effective treatment.  This 
note will examine whether the Americans with Disabilities Act 
(ADA) currently protects such individuals and recommend statutory 
changes that will ensure their protection.     
Part I will analyze the efficacy of medical marijuana and argue 
that further research is necessary.  Part II will discuss whether the 
ADA, in its current form, protects disabled persons for whom mari-
juana is an effective treatment.  Part III will propose statutory 
  
 10 Id. 
 11 Id.  
 12 Vanessa Ho, Woman Fired Over Medical Marijuana to Get Day in High 
Court, SEATTLE POST-INTELLIGENCER (Dec. 21, 2010), 
http://www.seattlepi.com/local/432234_medical+marijuana.html.   
 13 Id. 
 14 Id. 
 15 Id. 
 16 Id. 
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amendments to address the uncertain status of medical marijuana us-
ers under the ADA.   
 
I. MARIJUANA’S THERAPEUTIC VALUE  
A. The Center for Medicinal Cannabis Research 
In 2000, the University of California, San Diego, created the Cen-
ter for Medicinal Cannabis Research (CMCR), perhaps the most com-
prehensive attempt to investigate the medicinal value of marijuana to 
date.17  CMCR has completed five clinical studies and four pre-
clinical studies.18  Six of the studies have been published or submitted 
for publication in medical journals.19  There has long been serious 
doubt about the medical benefit of marijuana,20 but CMCR studies 
have helped erase that doubt.  Four CMCR studies showed that mari-
juana has an analgesic effect on nerve pain resulting from injury or 
disease, such as spinal cord injury or HIV.21  Three of those studies 
achieved good results for subjects who had found other painkillers 
  
 17 UNIV. OF CAL. CTR. FOR MEDICINAL CANNABIS RESEARCH, REPORT TO THE 
LEGISLATURE AND GOVERNOR OF THE STATE OF CALIFORNIA PRESENTING FINDINGS 
PURSUANT TO SB847 WHICH CREATED THE CMCR AND PROVIDED STATE FUNDING 2 
(Feb. 11, 2010) [hereinafter CMCR REPORT], 
http://www.cmcr.ucsd.edu/CMCR_REPORT_FEB17.pdf. 
 18 Id.  Several studies (most related to cancer) were discontinued because it 
was difficult to recruit severely ill participants due to the demanding research proto-
col.  Id. at 3.  
 19 The following studies have been published or submitted for publication: 
Donald I. Abrams, The Effect of Cannabis on Neuropathic Pain in HIV-Related Pe-
ripheral Neuropathy; Donald Abrams, Vaporization as a ‘Smokeless’ Cannabis De-
livery System; Jody Corey-Bloom, Short-Term Effects of Cannabis Therapy on Spas-
ticity in Multiple-Sclerosis; Ronald J. Ellis, Placebo-Controlled, Double Blind Trial 
of Medicinal Cannabis in Painful HIV Neuropathy; Mark Wallace, Analgesic Efficacy 
of Smoked Cannabis; Barth Wilsey, A Double-Blind, Placebo-Controlled Crossover 
Trial of the Antinociceptive Effects of Smoked Marijuana on Subjects with Neuro-
pathic Pain; synopsis of study results provided in CMCR REPORT, supra note 17, at 
10-12.  The following studies have not been published, but are completed or ongoing: 
Mark Barad, Cannabinoids in Fear Extinction; Sean Drummond, Sleep and Medicinal 
Cannabis; Thomas Marcotte, Impact of Repeated Cannabis Treatments on Driving 
Abilities; Daniele Piomelli, Effects of Cannabis Therapy on Endogenous Cannabi-
noids; Rachel Schrier, Effects of Medicinal Cannabis on CD4 Immunity in AIDS; 
Mark Wallace, Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropa-
thy; Barth Wilsey, The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain; 
Howard Fields, Mechanisms of Cannabinoid Analgesia; synopsis of study results 
provided in CMCR REPORT, supra note 17, at 13-15. 
 20 Gardiner Harris, F.D.A. Dismisses Medical Benefit from Marijuana, N.Y. 
TIMES, Apr. 21, 2006, at A1. 
 21 CMCR REPORT, supra note 17, at 2. 
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inadequate.22  Another study showed that marijuana also helps relieve 
headaches and facial pain.23  Thus, marijuana can, and does, play a 
particularly important role for individuals who are suffering from de-
bilitating pain and have exhausted other treatment options.     
Another CMCR study showed that marijuana has a positive im-
pact on muscle spasticity for persons with multiple sclerosis.24  Multi-
ple sclerosis causes “fatigue, loss of balance, muscle weakness, and 
muscle spasticity.”25  Muscle spasms can be painful and affect the 
ability to walk, take care of oneself, or manage everyday activities.26  
Current treatments for muscle spasticity provide inconsistent results, 
often with serious side effects.27  CMCR’s studies showed “significant 
improvement in both an objective measure of spasticity and pain in-
tensity” for patients who used medical marijuana after finding other 
treatments ineffective.28   
CMCR’s research regarding chronic pain is especially significant.  
Chronic pain is a widespread problem, estimated to affect 5–10 per-
cent of the population.29  It is caused by issues in the nervous system 
rather than stimulation of the pain receptors in nerve endings.30  The 
treatments available for such pain are rather limited, and their effec-
tiveness is inconsistent.31  CMCR’s studies on chronic pain demon-
strated “significant decrease in pain after cannabis administration.”32  
Marijuana’s effectiveness in treating chronic pain is an important de-
velopment with the potential to help many people, including employ-
ees who might otherwise be unable to work.  Marijuana could provide 
pain relief, increase productivity, and help individuals become more 
self-sufficient.   
In addition, the side effects experienced in these studies were 
typically mild, receded quickly, and “tended to be no worse” than 
those of other strong pain relievers.33  Side effects included “cough, 
nausea, dizziness, sedation and changes in cognition.”34  One of the 
studies also found that marijuana did not “interfere with the function 
  
 22 Id. 
 23 Id. at 3. 
 24 Id. at 9.   
 25 Id. 
 26 Id. 
 27 Id.  
 28 Id.  
 29 Id. at 8. 
 30 Id.  
 31 Id. 
 32 Id. at 9. 
 33 Id. at 3. 
 34 Id. 
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of blood cells involved with immunity,” an especially important con-
sideration for those who might use marijuana for chronic illness.35 
 
B. Current Uses of Medical Marijuana 
Medical applications of marijuana have, in many instances, pre-
ceded any formal scientific research.  Marijuana has been used to treat 
an array of physical and mental impairments, including multiple scle-
rosis, chronic pain, seizure disorders, anxiety disorders, severe nausea, 
glaucoma, schizophrenia, HIV/AIDS, and anorexia.36  As discussed in 
the introduction, Joseph Casias uses medical marijuana to relieve pain 
resulting from cancer, and Jane Roe treats the debilitating migraines 
she experiences.37  While these applications may not yet be fully sup-
ported by current findings, many patients have found medical mari-
juana to be an effective treatment.  
For example, the plight of redeploying soldiers suffering from 
post-traumatic stress disorder (PTSD) provides a compelling argu-
ment for medical marijuana.38  Paul Culkin was serving as member of 
an Army bomb squad in Kosovo in 2004 when he experienced the 
physical and mental trauma of a car bomb explosion.39  The memory 
of that explosion made it difficult for Culkin to readjust to his life in 
America; he has PTSD and experiences fits of anger and is wary of 
social situations.40  Culkin has found some relief through psychother-
apy and anti-depressants, but he also uses a marijuana extract that he 
dissolves in tea or hot chocolate.41  Culkin’s wife Victoria attests to 
the effectiveness of this treatment.  She believes it has made her hus-
band a “different,” “better,” “more open,” and “more communicative” 
person.42  According to Victoria, medical marijuana “saved our mar-
riage and our family.”43   
Paul Culkin’s story exemplifies the controversy and contradic-
tions that surround medical marijuana use.  New Mexico, where the 
  
 34 Id. 
 36 Medical Uses, INT’L ASS’N FOR CANNABINOID MED., http://www.cannabis-
med.org/index.php?tpl=page&id=21&lng=en (last visited Jan. 7, 2012); James Mac-
Donald, Medical Marijuana: Informational Resources for Family Physicians, 80 AM. 
FAM. PHYSICIAN 782, 783 (2009), available at 
http://www.aafp.org/afp/2009/1015/p779.html.    
 37 See supra notes 5-16 and accompanying text. 
 38 Jeff Brady, Can Marijuana Ease PTSD? A Debate Brews, NPR (May 19, 
2010), http://www.npr.org/templates/story/story.php?storyId=126827410. 
 39 Id.  
 40 Id.  
 41 Id. 
 42 Id.  
 43 Id.   
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Culkin’s live, has approved medical marijuana use for PTSD, while 
neighboring Colorado recently prohibited that specific use.44  Al-
though legal in New Mexico, Culkin has had to pay out-of-pocket for 
his treatment because the Department of Veteran’s Affairs refuses to 
pay for medical marijuana use.45  The importance of helping people 
like Paul Culkin reinforces the need to accelerate medical research so 
that the therapeutic benefits of marijuana can be expanded.   
 
C. Further Research Recommended 
In 2009, the American Medical Association (AMA) took a strong 
stand in favor of more research into the medicinal value of mari-
juana.46  It reported that certain clinical trials showed a positive effect 
on neuropathic pain, muscle spasticity, and pain resulting from multi-
ple sclerosis.47  The AMA recommended that the federal government 
review the status of marijuana under the CSA because its current 
status “inhibits research on its potential medical benefits.”48  At the 
time of publishing of the AMA’s report, “less than 20 small random-
ized controlled trials of short duration involving ~300 patients ha[d] 
been conducted in the last 35 years.”49  The AMA called for “adequate 
and well-controlled studies of marijuana and related cannabinoids in 
patients who have serious conditions for which preclinical, anecdotal, 
or controlled evidence suggests possible efficacy . . . .”50 
A position paper of the American College of Physicians (ACP) 
adopted a similar stance.  The paper highlighted disagreement be-
tween the scientific community and federal agencies concerning the 
medicinal value of marijuana.51  The ACP expressed optimism about 
the potential usefulness of marijuana, particularly for patients who 
may have exhausted other treatment options.52  And, pursuing more 
  
 44 Id. 
 45 Id. 
 46 Scott Hensley, AMA Broadens Its Social Agenda, NPR’S HEALTH BLOG 
(Nov. 12, 2009, 10:56 AM), 
http://www.npr.org/blogs/health/2009/11/what_is_the_ama.html.   
 47 AM. MED. ASS’N, REPORT 3 OF THE COUNCIL ON SCIENCE AND PUBLIC 
HEALTH (I-09): USE OF CANNABIS FOR MEDICINAL PURPOSES 12 (2009) [hereinafter 
AMA REPORT 3], available at http://www.ama-
assn.org/resources/doc/csaph/i09csaph3ft.pdf.   
 48 Hensley, supra note 46.   
 49 AMA REPORT 3, supra note 47, at EXECUTIVE SUMMARY. 
 50 Id. at 16.   
 51 TIA TAYLOR, AM. COLL. OF PHYSICIANS, SUPPORTING RESEARCH INTO THE 
THERAPEUTIC ROLE OF MARIJUANA 8 (2008), available at 
http://www.acponline.org/advocacy/where_we_stand/other_issues/medmarijuana.pdf.   
 52 Id.   
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research would help clarify marijuana’s therapeutic properties.53   
Unfortunately, without changing the status of medical marijuana un-
der the CSA, it will be difficult to complete such research.54   
 
II.  MARIJUANA AND THE ADA55 
The purpose of the ADA is “to provide a clear and comprehensive 
national mandate for the elimination of discrimination against indi-
viduals with disabilities . . . .”56  Subchapter I of the ADA prohibits 
employers from discriminating against employees or applicants on the 
basis of disability.57   The ADA was amended in 2008 to relax the 
threshold determination of whether or not an individual actually suf-
fers from a disability that entitles them to the protections of the 
ADA.58  The Equal Employment Opportunity Commission (EEOC) 
has provided examples that illustrate the ADA’s definition of disabil-
ity.59  For the purposes of this Note, it is sufficient to say that many 
  
 53 Id. at 1, 9. 
 54 Id. at 1. 
 55 For a thorough discussion of many of the issues infra Part II, see generally 
Ari Lieberman & Aaron Solomon, A Cruel Choice: Patients Forced to Decide Be-
tween Medical Marijuana and Employment, 26 HOFSTRA LAB. & EMP. L.J. 619, 633-
57 (2009).   
 56 42 U.S.C. § 12101(b)(1) (2006) amended by ADA Amendments Act of 
2008, Pub. L. No. 110-325, sec. 3, § 12101, 122 Stat. 3554. 
 57 Id. § 12112(a) (Supp. II 2006). 
 58 The basic definition remains the same:  a disability is “a physical or mental 
impairment that substantially limits one or more major life activities of such individ-
ual…a record of such an impairment…or being regarded as having such an impair-
ment.”  Id. § 12102(1) amended by ADA Amendments Act of 2008, Pub. L. No. 110-
325, sec. 4, § 12102, 122 Stat. 3555.  However, the meaning has changed.  EEOC, 
SUMMARY OF KEY PROVISIONS:  EEOC’S NOTICE OF PROPOSED RULINGMAKING 
(NPRM) TO IMPLEMENT THE ADA AMENDMENTS ACT OF 2008 (ADAAA) 1, 
http://www.eeoc.gov/laws/regulations/upload/adaaa-summary.pdf (last visited Mar. 
14, 2011) [hereinafter EEOC SUMMARY OF KEY PROVISIONS]. 
 59 “Examples Illustrating Definition of Disability 
• Impairments for which an individualized assessment “can be conducted 
quickly and easily, and that will consistently result in a determination that 
the person is substantially limited in a major life activity”: deafness, blind-
ness, intellectual disability (formerly known as mental retardation), partially 
or completely missing limbs, mobility impairments requiring use of a 
wheelchair, autism, cancer, cerebral palsy, diabetes, epilepsy, HIV/AIDS, 
multiple sclerosis, muscular dystrophy, major depression, bipolar disorder, 
post-traumatic stress disorder, obsessive-compulsive disorder, and schizo-
phrenia.  
• Impairments that may be substantially limiting for some individuals but not 
for others, and therefore may require somewhat more, though still not ex-
tensive, analysis: asthma, high blood pressure, back and leg impairments, 
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individuals using medical marijuana suffer from conditions that are 
disabilities according to the ADA.60  This section will focus on the 
major hurdles that are uniquely relevant to a claim brought by a dis-
abled person using medical marijuana.   
 
A. Illegal Use of Drugs 
When an employer takes adverse action on the basis of illegal use 
of drugs, the employee or applicant is not protected by the ADA.61  
The Supreme Court has clearly held that medical marijuana use, even 
if authorized by state law, is illegal under the CSA.62  However, the 
question here is whether or not the ADA regards such use as illegal.  
If so, an employer can take adverse action on the basis of prescription 
marijuana use without fear of liability.  The ADA defines “illegal use 
of drugs” as follows: 
 
The term “illegal use of drugs” means the use of drugs, 
the possession or distribution of which is unlawful un-
der the Controlled Substances Act . . . Such term does 
not include the use of a drug taken under supervision 
by a licensed health care professional, or other uses 
authorized by the Controlled Substances Act or other 
provisions of Federal law.63 
 
Thus, the question is, does the ADA simply mirror the CSA, or does 
the ADA offer a more narrow view of what constitutes an illegal use 
of drugs?  
  
learning disabilities, panic or anxiety disorders, some forms of depression, 
carpal tunnel syndrome, and hyperthyroidism. 
• Temporary, non-chronic impairments of short duration with little or no re-
sidual effects that usually will not substantially limit a major life activity: 
common cold, seasonal or common influenza, a sprained joint, minor and 
non-chronic gastrointestinal disorders, a broken bone expected to heal com-
pletely, appendicitis, and seasonal allergies. 
• However, an impairment may still be substantially limiting even if it lasts or 
is expected to last fewer than 6 months, such as a 20-pound lifting restric-
tion lasting several months.   
EEOC SUMMARY OF KEY PROVISIONS, supra note 58, at 2.     
 60 See supra Part I.A-B; see supra note 58.   
 61 42 U.S.C. § 12114(a) (Supp. II 2006) (“For purposes of this subchapter, a 
qualified individual with a disability shall not include any employee or applicant who 
is currently engaging in the illegal use of drugs, when the covered entity acts on the 
basis of such use.”).  Id. § 12210(a). 
 62 Gonzales v. Raich, 545 U.S. 1, 28-29 (2005). 
 63 § 12111(6)(A). 
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1. Current Federal Court Interpretation  
Only twice have federal courts addressed whether or not use of 
medical marijuana, when legal under state law, is considered an illegal 
use of drugs by the ADA.64  In Barber v. Gonzales,65 James Barber 
sought reconsideration of his case in light of the Supreme Court’s 
landmark decision in Gonzales v. Raich, which determined that medi-
cal marijuana use is illegal under the CSA.66  Barber was kicked out 
of university housing at Washington State University because of his 
marijuana use, and he had previously been arrested in Oregon for cul-
tivating marijuana.67  Barber asserted that he used the marijuana for 
medical reasons, although it is not clear from his rather wordy and 
imprecise complaint whether or not a doctor had actually prescribed 
the marijuana.68  Barber claimed that his eviction was unlawful, ap-
parently invoking the public services and public accommodation sub-
chapters of the ADA.69   
In rejecting Barber’s claim, the district court invoked the ADA’s 
illegal drug provision.70  The court held that the second sentence of 
the definition—“[s]uch term does not include the use of a drug taken 
under supervision by a licensed health care professional, or other uses 
authorized by the Controlled Substances Act or other provisions of 
Federal law”71—must be read consistently with the CSA.  Under the 
CSA, marijuana is a Schedule I drug, and, as such, even medical use 
is not permitted.72  The court rejected the idea that the ADA’s defini-
tion included a distinct meaning for uses under medical supervision.73  
Instead, it determined that the second sentence of the definition was 
merely a reiteration of the first sentence, indicating that illegal drug 
  
 64 Barber v. Gonzales, No. CV-05-0173-EFS, 2005 WL 1607189 (E.D. 
Wash. July 1, 2005); James v. City of Costa Mesa, No. SACV 10-0402 AG (MLGx), 
2010 WL 1848157 (C.D. Cal. Apr. 30, 2010).   
 65 Barber, 2005 WL 1607189 (E.D. Wash. July 1, 2005). 
 66 Individuals using marijuana under California’s Compassionate Use Act 
challenged the constitutionality of the CSA’s complete ban on marijuana.  The Su-
preme Court upheld the constitutionality of the prohibition, as a valid exercise of 
Congress’s Commerce Clause power.  Gonzales, 545 U.S. at 9 (2005). 
 67 Complaint at 30, Barber v. Gonzales, 2005 WL 1607189 (E.D. Wash. July 
1, 2005) (No. CV-05-0173-EFS). 
 68 Id. at 5-6. 
 69 The complaint is long and difficult to understand, and the above explana-
tion is probably the best guess as to the basis of his claim.  Id. at 18. 
 70 Barber, 2005 WL 1607189, at *1. 
 71 42 U.S.C. § 12111(6)(A). 
 72 See 21 C.F.R. § 1308.11 (2011). 
 73 Barber, 2005 WL 1607189, at *1. 
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use is that which violates the CSA.74  In other words, “it is immaterial 
whether such drug use is authorized by state law.”75   
In James v. City of Costa Mesa, several plaintiffs sought a pre-
liminary injunction to prevent the cities of Costa Mesa and Lake For-
est, California, from shutting down collectives that supplied the plain-
tiffs with medical marijuana.76  The plaintiffs argued that the public 
accommodations subchapter of the ADA protected their right as dis-
abled citizens to use medical marijuana in accordance with state law.77  
They sought a “reasonable accommodation from Defendants’ zoning 
laws and policies to obtain access to medical marijuana to treat their 
disabilities.”78  This is not an employment case, but it is relevant be-
cause the district court denied the injunction based on its interpreta-
tion of the term “illegal use of drugs,” a definition that also applies to 
the employment subchapter.79   
Plaintiffs, the court decided, were not entitled to relief under the 
ADA because they were engaged in illegal drug use.  In determining 
the meaning of the second sentence of the “illegal use of drugs” defi-
nition, the court emphasized the relationship between the first clause 
(“[s]uch term does not include the use of a drug taken under supervi-
sion by a licensed health care professional”) and the second clause 
(“or other uses authorized by the Controlled Substances Act or other 
provisions of Federal law”).80   The court placed particular emphasis 
on the word “other” in the second clause, arguing that its presence 
indicates that the meaning of the first clause depends on the second.81  
The first clause describes one type of use authorized by the CSA, 
while the second clause “encompasses all of the ‘other’ authorized 
uses” contemplated by the CSA.82  In other words, the ADA’s defini-
tion of “illegal use of drugs” mirrors the CSA.  As a result, the plain-
tiffs were barred from bringing an ADA claim despite taking mari-
juana under the supervision of licensed healthcare professionals. 
 
  
 74 Id. 
 75 Id.  
 76 James v. City of Costa Mesa, No. SACV 10-0402 AG (MLGx), 2010 WL 
1848157, at *1 (C.D. Cal. Apr. 30, 2010). 
 77 Id. at *1.   
 78 Id. at *2. 
 79 Id. (quoting 42 U.S.C. § 12210(d) (2006)).   
 80 Id. (quoting § 12210(d)). 
 81 Id. 
 82 Id. 
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2. Alternative Interpretation 
These unreported district court opinions do not articulate the only 
or best interpretation of the definition of “illegal use of drugs.”  The 
Code of Federal Regulations includes a section intended to clarify the 
ADA’s definition of “illegal use of drugs”:   
 
The Act and the regulation distinguish between illegal 
use of drugs and the legal use of substances, whether 
or not those substances are “controlled substances,” as 
defined in the Controlled Substances Act (21 U.S.C. 
812).  Some controlled substances are prescription 
drugs that have legitimate medical uses.  Section 
36.209 does not affect use of controlled substances 
pursuant to a valid prescription, under supervision by a 
licensed health care professional, or other use that is 
authorized by the Controlled Substances Act or any 
other provision of Federal law.83 
 
This explanation retains some of the ambiguity of the ADA (including 
that troublesome word “other”), but it more clearly focuses on pre-
scribed substances as a legitimate and distinct use under the ADA.     
The district courts, in the cases discussed above, held that the sec-
ond sentence of the definition of “illegal use of drugs” simply ex-
plains what uses are permitted by the CSA.  However, this interpreta-
tion renders most of the definition redundant or superfluous.  If Con-
gress intended that the definition be synonymous with the CSA, the 
drafters could have stopped after the first sentence—“The term ‘ille-
gal use of drugs’ means the use of drugs, the possession or distribu-
tion of which is unlawful under the Controlled Substances Act.”84  
The CSA thoroughly explains how the various substances may or may 
not be used, and there is no need for an explanatory sentence if the 
ADA’s definition simply mirrors the CSA.   
Full effect can be given to both sentences in the following man-
ner.  The first sentence sets forth a general rule: if a drug is illegal 
under the CSA, an employer will not face ADA liability if adverse 
action is taken on the basis of such drug use.  The second sentence 
carves out exceptions to that rule: (1) uses under licensed medical 
supervision, (2) uses authorized by the CSA, and (3) uses authorized 
by other federal laws.  Medical licensing is in the domain of state 
  
 83 28 C.F.R. pt. 36, app. B, § 36.209 (2011). 
 84 § 12111(6)(A). 
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law;85 therefore, when a licensed doctor prescribes marijuana pursuant 
to state law, the marijuana user is not engaged in an “illegal use of 
drugs” under the ADA, even though she is violating the CSA.86     
 
3. ADA Not Intended to Exclude Treatment 
Choices 
The ADA’s illegal drug provision is intended to preclude indi-
viduals from claiming current drug use or addiction as a disability 
covered by the ADA: “[A] qualified individual with a disability shall 
not include any employee or applicant who is currently engaging in 
the illegal use of drugs, when the covered entity acts on the basis of 
such use.”87  (The action of a covered entity refers to an employer 
taking adverse steps against an individual—firing an employee, for 
example.)  In the present context, however, medical marijuana users 
are not seeking to have their prescription drug use treated as a disabil-
ity.  They already have underlying disabilities, which serve as the 
basis for an ADA claim.  Although the above-referenced district court 
opinions imply otherwise, the ADA addresses drug use as disability 
and says nothing about drug use as treatment.   
As the plaintiffs argued in James v. City of Costa Mesa, the initial 
draft of the ADA did not exclude coverage for those engaged in the 
illegal use of drugs.88  That exclusion was added because of abuses 
that had occurred under the Rehabilitation Act.89  Senator Jesse Helms 
supported the amendment because he believed that the war on drugs 
would fail if drug abusers could “hide behind the laws designed to 
help those who are seriously handicapped.”90  Helms was upset that 
  
 85 Medical Licensure, AM. MED. ASS’N, http://www.ama-
assn.org/ama/pub/education-careers/becoming-physician/medical-licensure.page? 
(last visited Jan. 6, 2012); What is a State Medical Board?, FED’N OF STATE MED. 
BDS., available at http://www.fsmb.org/pdf/what-is-smb.pdf (last visited Jan. 6, 
2012).   
 86 For further discussion of the legislative history of the ADA, see Lieberman 
& Solomon, supra note 55, at 650-53. 
 87 42 U.S.C. § 12114(a) (Supp. II. 2006). 
 88 Memorandum in Opposition to Defendant Costa Mesa’s Motion to Dis-
miss at 12-14, James v. City of Costa Mesa, No. SACV 10-0402 AG (MLGx), 2010 
WL 1848157 (C.D. Cal. Apr. 30, 2010), 2010 WL 2934614.   
 89 The Rehabilitation Act was the predecessor to the ADA.  Id. at 12. 
 90 101 CONG. REC. S10775 (Sept. 7, 1989) (statement of Sen. Jesse Helms), 
available at http://thomas.loc.gov/home/LegislativeData.php?&n=Record&c=101 
(search “Search Congressional Record – 101st Congress”: select “HELMS, Jesse 
(NC) from the ‘Member of Congress’ menu”; search “Americans with Disabilities 
Act”; then follow the hyperlink for “September 07, 1989”) (last visited Jan. 9, 2012), 
cited in Memorandum in Opposition to Defendant Costa Mesa’s Motion to Dismiss, 
supra note 88, at 12.   
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federal law treated current drug abuse as a disability.91  The primary 
concern was with drug abusers being categorized as disabled, as op-
posed to concern that otherwise illegal drugs could be prescribed to 
treat disabilities.  Medical marijuana users are not drug abusers; they 
have serious health issues and are taking marijuana pursuant to a law-
ful prescription.     
The House Report that accompanied the ADA prior to its passage 
in 1990 made clear that the new illegal drug provision was not in-
tended to affect disabled persons taking drugs under supervision of a 
licensed health care professional:    
 
The term “illegal drugs” is defined in section 101(5) 
and does not include drugs taken under supervision by 
a licensed health care professional.  The exempted 
category includes, for example, experimental drugs 
taken under supervision.  Many people with disabili-
ties, such as people with epilepsy, AIDS, and mental 
illness, take a variety of drugs, including experimental 
drugs, under supervision by a health care professional.  
Discrimination on the basis of use of such drugs would 
not be allowed.92  
 
This passage only explicitly mentions experimental drugs as an exam-
ple.  However, it places special emphasis on whether or not a particu-
lar drug is used pursuant to licensed supervision.  This particular focus 
supports an understanding of “illegal use of drugs” that allows for 
supervised medical use regardless of a drug’s status under criminal 
statutes like the CSA.    
The executive branch took a similar position and relayed its con-
cern to Congress.  Deputy Assistant Attorney General John Mackey 
wrote a letter to the Senate Committee stating that the Bush admini-
stration did not want to exclude from ADA protection individuals who 
were using controlled substances in the course of treatment.93  The 
evidence surrounding the ADA’s legislative history indicates that pre-
scription drug treatment should not disqualify disabled persons from 
seeking the protection of the ADA.    
  
 91 101 CONG. REC. S10775. 
 92 H.R. REP. 101-485, pt. 2, at 79 (1989), reprinted in 1990 U.S.C.C.A.N. 
303, 361. 
 93 Hearings on S.933 Before the S. Comm. on Labor and Human Resources, 
101st Cong. 828 (1989) (statement of John P. Mackey, Deputy Att’y Gen.), cited in 
Memorandum in Opposition to Defendant Costa Mesa’s Motion to Dismiss, supra 
note 88, at 12-13. 
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B. Discrimination on the Basis of Disability 
A disabled person bringing an ADA claim must show that she was 
subjected to discrimination “on the basis of disability.”94  Employers 
who take action against medical marijuana users will argue that it was 
directed at the employee’s misconduct and has nothing to do with the 
individual’s disability.  At first glance, it may appear that the dis-
criminatory action is focused on the employee’s behavior, and not the 
underlying disability.  However, there is good reason to believe that 
such adverse action is prohibited by the ADA.   
 
1. Reasonable Accommodation 
Discrimination on the basis of disability includes “not making 
reasonable accommodations to the known physical or mental limita-
tions” of a disabled employee 95 or denying an employment opportu-
nity to a person who needs accommodation. 96  An employer can avoid 
making reasonable accommodation only when it would impose an 
“undue hardship.”97  Reasonable accommodation helps remove the 
barriers that often prevent disabled persons from accessing equal op-
portunities.98   
Reasonable accommodation can take many forms.  It might in-
clude improving facility accessibility, job restructuring, modified 
scheduling, modified equipment, or even job reassignment.99  A claim 
of undue hardship is supported by an “individualized assessment” of 
the cost and difficulty of implementing a particular accommodation.100  
Undue hardship is determined by looking at several factors: (1) the 
nature and cost of accommodation, (2) the overall financial resources 
of the employer or facility, (3) the type of operation of the employer, 
and (4) the impact of the accommodation.101       
For a disabled person whose best treatment option is marijuana, 
reasonable accommodation could be as simple as altering the em-
  
 94 42 U.S.C. § 12112(a) (Supp. II 2006).   
 95 Id. § 12112(b)(5)(A). 
 96 Id. § 12112(b)(5)(B). 
 97 Id. § 12112(b)(5)(A). 
 98 29 C.F.R. § 1630.9 (2011). 
 99 EEOC, NOTICE NO. 915.002, ENFORCEMENT GUIDANCE: REASONABLE 
ACCOMMODATION AND UNDUE HARDSHIP UNDER THE AMERICANS WITH DISABILITIES 
ACT (Oct.17, 2002), available at 
http://www.eeoc.gov/policy/docs/accommodation.html. 
 100 Id. 
 101 Id. 
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ployer’s drug policy.  EEOC guidelines state that an employee’s dis-
ability may necessitate modifying workplace policies, and that such 
modifications constitute reasonable accommodation if the employer 
does not suffer an undue hardship.102  Under the ADA, the employer 
is not required to entirely discard the discriminatory policy.  A policy 
still can be enforced with regard to all other employees; the employer 
only needs to make an exception for the disabled employee.103   
As an example, the guidelines discuss an employee suffering from 
diabetes.  The employer might have to modify a strict office food ban 
in order to accommodate the employee’s specific needs.104  With re-
gard to medical marijuana, an employer could make an exception to a 
strict prohibition against marijuana use for those employees who are 
using it pursuant to state medical marijuana laws and under profes-
sional medical supervision.  In analyzing the undue hardship factors, 
the accommodation proposed may be reasonable for many employers 
because (1) the cost would be low, and (2) the overall financial re-
sources of the employer or facility would not be strained.  The last 
two factors will depend upon the job, because the side effects of mari-
juana will have a different impact depending upon the job or work-
place.  Absent undue hardship, the ADA prohibits an employer from 
either refusing to accommodate or taking adverse action because of 
the need to accommodate an employee.105  
    
2. Policies That Screen Out Disabled Persons 
The ADA also states that discrimination on the basis of disability 
includes  
 
[u]sing qualification standards, employment tests or 
other selection criteria that screen out or tend to screen 
out an individual with a disability or a class of indi-
viduals with disabilities unless the standard, test or 
other selection criteria, as used by the covered entity, 
is shown to be job-related for the position in question 
and is consistent with business necessity.106   
 
The ADA provides employers wide latitude in drug testing their em-
ployees.  Tests for illegal drugs are not subject to the same restrictions 
  
 102 Id.  
 103 Id. 
 104 Id. 
 105 42 U.S.C. § 12112(b)(5)(A) (2006).   
 106 Id. § 12112(b)(6).   
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as medical examinations.107   As a result, it is permissible for employ-
ers to test for the presence of marijuana.  Even if it is established that 
medical marijuana is not an illegal use of drugs, nonmedical use re-
mains illegal and the employer is entitled to test for it.   
Despite the lawfulness of testing for marijuana, if an employer 
uses the results of the test in a way that “tends to screen out” disabled 
persons, the employer is engaging in unlawful discrimination, absent a 
showing of business necessity.108  An employer can establish business 
necessity if it reasonably believes that the employee, because of im-
pairment, cannot perform essential job functions or will pose a direct 
threat to the health and safety of herself or her coworkers.109  
Recently, a federal district court decided a case that is an excellent 
analogue for medical marijuana use.  In Bates v. Dura Automotive 
Systems, several former employees of Dura Automotive Systems 
brought suit after being fired for testing positive for certain legal pre-
scription drugs.110  In response to increased numbers of workplace 
injuries, the company had adopted a policy that prohibited any drug 
that carried a safety warning about operating machinery while using 
the drug.111  Dura sought summary judgment, arguing that its policy 
did not screen out disabled individuals, but instead screened out indi-
viduals who were using certain legal and illegal drugs.112  The court 
rejected this argument because testing for certain drugs, which are 
used to treat serious physical and mental ailments, “clearly tends to 
screen out” disabled individuals.113   
Dura also argued that the screening was job-related and consistent 
with business necessity since Dura instituted the policy to improve the 
safety of a facility that had been more accident prone than others.114  
Dura argued that they ought to be able to take this preemptive action 
  
 107 Id. § 12114(d)(1); EEOC, NOTICE NO. 915.002, ENFORCEMENT GUIDANCE:  
DISABILITY-RELATED INQUIRIES AND MEDICAL EXAMINATIONS OF EMPLOYEES UNDER 
THE AMERICANS WITH DISABILITIES ACT (ADA) (July 27, 2000) [hereinafter EEOC 
DISABILITY-RELATED INQUIRIES] (“The ADA’s provisions concerning disability-
related inquiries and medical examinations reflect Congress’s intent to protect the 
rights of applicants and employees to be assessed on merit alone, while protecting the 
rights of employers to ensure that individuals in the workplace can efficiently perform 
the essential functions of their jobs.”), available at 
http://www.eeoc.gov/policy/docs/guidance-inquiries.html#5. 
 108 § 12112(b)(6).   
 109 EEOC DISABILITY-RELATED INQUIRIES, supra note 107. 
 110 Bates v. Dura Auto. Sys., 650 F. Supp. 2d 754, 760-63 (M.D. Tenn. 2009). 
 111 Id. at 770. 
 112 Id. 
 113 Id. (internal quotations omitted). 
 114 Id. at 758, 770. 
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to protect employees and avoid potential liability.115  The court 
pointed out that there needs to be “some realistic connection between 
the medical screening and the work performed.”116  While Dura’s goal 
of workplace safety was legitimate, Dura did not appear to take into 
account “individualized circumstances,” and it reflexively fired any 
worker taking prohibited medications.117  The court found the inflexi-
bility of the policy problematic and denied Dura’s motion for sum-
mary judgment.118  In addition, the court held that the determination of 
business necessity was best left to a jury.119  
The determination of business necessity is based on “individual-
ized circumstances.”120   Inflexible prohibitions of medical marijuana 
short circuit the thoughtful deliberation that the ADA requires before 
a decision to fire an employee on the basis of the medical treatment 
they need for a disability.  In some cases, it may be appropriate to 
prohibit medical marijuana (e.g., airline pilots or structural steel 
workers might pose a direct threat to the health and safety of them-
selves or others if they used medical marijuana).  In other cases, how-
ever, it is difficult to imagine that the relatively mild side effects of 
marijuana would prevent the employee from performing essential job 
functions121 (e.g., the email and telephone customer service position 
held by Jane Roe).122  The employer must have a “reasonable belief, 
based on objective evidence” that taking adverse action is consistent 
with business necessity.123  Otherwise, an employer cannot use a 
qualification standard or the results of a drug test in a way that “tends 
to screen out” disabled persons.  
 
3. Discrimination Construed Broadly 
ADA case law indicates that, generally, discrimination on the ba-
sis of disability is interpreted broadly.  Often, an employer’s animus is 
not aimed directly at a disability.  Instead, an employer’s adverse ac-
tion may be directed at something related to the disability, such as the 
inconvenience of accommodating a disabled person.  As a result, 
  
 115 Id. at 770.   
 116 Id. 
 117 Id. at 771-72. 
 118 Id. at 772. 
 119 Id. 
 120 Id. 
 121 See supra notes 33-35 and accompanying text; see also Marijuana, NAT’L 
INST. ON DRUG ABUSE, http://www.nida.nih.gov/DrugPages/Marijuana.html (last 
visited Jan. 17, 2011).   
 122 See supra note 14 and accompanying text.  
 123 EEOC DISABILITY-RELATED INQUIRIES, supra note 107.  
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some courts and the EEOC have interpreted “on the basis of disabil-
ity” broadly.   
Several cases related to methadone treatment facilities provide an 
example of the tendency to read “on the basis of disability” broadly.  
Methadone is a restricted drug that is used primarily for drug addic-
tion treatment programs.124  Because of this use, both Methadone clin-
ics and users have often been looked upon with suspicion.125  Much of 
the jurisprudence is focused on “regarded as” claims,126 but a Third 
Circuit zoning decision provided guidance that highlights the bounda-
ries of discrimination.   In New Directions Treatment Services v. City 
of Reading, a Pennsylvania statute restricted the location of metha-
done clinics.127  The clinic and its patients brought suit based on the 
Equal Protection Clause and the ADA.  The court stated that the stat-
ute “facially singles out methadone clinics, and thereby methadone 
patients, for different treatment, thereby rendering the statute facially 
discriminatory.”128  The case may be distinguishable from the plight 
of employees using medical marijuana in two ways: (1) the claim is 
based upon zoning discrimination and not employment discrimina-
tion, and (2) the statute was enacted because of residents’ fears about 
the recovering addicts who would use the methadone clinic in their 
neighborhood.  But, importantly, the court viewed discrimination di-
rected at a particular treatment program as discrimination against 
disabled persons.  Treating a person with a disability differently be-
cause of their chosen treatment program constitutes “different treat-
ment” that is actionable under the ADA.       
The Tenth Circuit’s understanding of conduct related to a disabil-
ity also sheds light on the type of discriminatory behavior that the 
  
 124 Methadone, NAT’L CTR. FOR BIOTECHNOLOGY INFO., U.S. NAT’L LIBRARY 
OF MED., http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000591#a682134-why 
(last updated Feb. 1, 2009).    
 125 Julie Manganis, Methadone Clinic Appeals Denial of Permit, SALEM NEWS 
(Jan. 15, 2011), http://www.salemnews.com/local/x233316319/Methadone-clinic-
appeals-denial-of-permit (zoning board “found that the clinic would create ‘substan-
tial detriment’ to the surrounding community . . . .”); Scott Taylor, Site for Methadone 
Clinic Wrong, Neighbors Say, SUN JOURNAL (Jan. 14, 2011), 
http://www.sunjournal.com/city/story/970513 (the owner of a daycare near a pro-
posed methadone clinic commented, “You can bring us in and educate us about what 
you do. But can you bring all the parents in here? The ones who will stop coming 
when they find out how close you are to our door?”). 
 126 42 U.S.C. § 12102(2)(C) (2006), amended by ADA Amendments Act of 
2008, Pub. L. No. 110-325, sec. 4, § 12102, 122 Stat. 3555 (codified as amended at 
42 U.S.C. § 12102(1)(C)).   
 127 New Directions Treatment Services v. City of Reading, 490 F.3d 293, 298 
(3d Cir. 2007). 
 128 Id. at 304.   
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ADA prohibits.  In both Den Hartog v. Wasatch Academy129 and Niel-
sen v. Moroni Feed Company,130 the Tenth Circuit rejected a “stark 
dichotomy” between a disability and disability-caused misconduct.  
The employees who brought the claims did not prevail in either case, 
but the court did clarify how conduct related to a disability ought to be 
understood.  In Nielsen, the court explained that abnormal behavior 
that an employer treated as “misconduct” could be protected by the 
ADA because it was caused by mental illness.131  Normally, conduct 
caused by a disability should be afforded the same protection as the 
disability itself.132   Again, medical marijuana use may be distinguish-
able: it is not a symptom of the underlying disability in the way that 
abnormal behavior is a symptom of mental illness.  But, the Tenth 
Circuit’s approach may be relevant to the issue of medical marijuana 
use because the court framed the issue in broader terms—the ADA 
can apply to behavior or “misconduct” that is related to, or caused by, 
a disability. 
As long as an employee can perform the essential functions of the 
job, an employer ought to tolerate behavior that is caused by, or di-
rectly related to, a disability.  For example, “an employer must make 
an exception to a general policy requiring employees to be neat and 
courteous in order to accommodate a mentally disabled employee 
whose job does not involve interaction with customers or co-
workers.”133  Similarly, an employer ought to make an exception to a 
general policy prohibiting the use of marijuana to accommodate an 
employee whose disability is best treated with medical marijuana.    
Moreover, EEOC guidance reflects the Third and Tenth Circuit 
approach and supports the idea that a course of treatment (or, from the 
employer’s perspective, misconduct) should be handled the same as 
the disability itself.  One EEOC example, contained in the guidance, 
states that employee misconduct stemming from the side effects of a 
medication should be accommodated unless it creates an undue hard-
ship.134  Similarly, medical marijuana use is directly related to, and 
caused by, the underlying disability.  The need for treatment is a direct 
result of the disability.  Many employers regard medical marijuana 
use as misconduct.  If that misconduct—which, in reality, is simply 
  
 129 Den Hartog v. Wasatch Acad., 129 F.3d 1076, 1088 (10th Cir. 1997). 
 130 Nielsen v. Moroni Feed Co., 162 F.3d 604, 608 (10th Cir. 1998). 
 131 Id. 
 132 Id.   
 133 Id. (citing EEOC, NOTICE NO. 915.002, EEOC ENFORCEMENT GUIDANCE 
ON THE AMERICANS WITH DISABILITIES ACT & PSYCHIATRIC DISABILITIES (Mar. 25, 
1997) [hereinafter EEOC ENFORCEMENT GUIDANCE ON THE ADA], available at 1997 
WL 34622315, at *15). 
 134 EEOC ENFORCEMENT GUIDANCE ON THE ADA, supra note 133, at *15. 
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prescription drug use—is caused by the disability, the employer dis-
criminates by refusing to accommodate it. 
 
C.  Recommendations for Employers 
How should employers change their policies and practices in 
states where medical marijuana is legal?  Employer policies and ac-
tions should be founded on two inquiries.  First, is the employee’s use 
of marijuana permitted by state law and supervised by a licensed 
medical professional?  Second, how will medical marijuana use affect 
the employee and the workplace?  If the employee chooses to bring a 
reasonable accommodation claim, the employer must show that per-
mitting medical marijuana use will constitute an undue hardship.135  If 
the employee chooses to challenge the policy, as tending to screen out 
disabled persons, the employer must show that the policy is job-
related and consistent with business necessity.136     
Employers may still test for the presence of illegal drugs, includ-
ing marijuana.  If an employee tests positive for marijuana in a state 
where medical use is legal, the employer should provide the employee 
with an opportunity to produce documentation that the marijuana is 
lawfully prescribed.  If an employer wishes to take adverse action 
because of medical marijuana use, it must bear the burden of demon-
strating that accommodation creates an undue hardship or that the 
decision is job-related and consistent with business necessity.  The 
employer ought to engage in a dialogue with the employee to ensure 
that any decision is based on an individualized analysis of the facts.   
 
III. STATUTORY SOLUTIONS 
This Note contends that there is reason to believe that the ADA 
protects disabled employees who use medical marijuana.  However, 
the path to relief could be made clearer if certain changes were made 
to federal law.  While I disagree with the unreported decision of the 
district court in James v. City of Costa Mesa, the court highlighted 
what could be a recurring theme for plaintiffs: 
 
The record and arguments in this case stimulate 
thoughts on many other questions concerning medical 
marijuana, the rights of the seriously ill, and the inter-
play between federal, state, and municipal law. Were 
our federal statutes written differently, the Court 
  
 135 42 U.S.C. § 12112(b)(5)(A) (2006). 
 136 Id. § 12112(b)(6).   
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would have the chance to contribute to the growing 
body of scholarship on these questions.137 
 
Below are suggestions as to how to write those statutes differently.   
 
A. ADA Revision 
The ADA, in its current form, does not provide a clear enough di-
rective regarding what constitutes the illegal use of drugs.  More spe-
cifically, the status of disabled persons lawfully using medical mari-
juana under state law is unacceptably uncertain with regard to federal 
protection against discrimination.  The ADA definition of “illegal use 
of drugs” should be revised to protect individuals who use marijuana 
in compliance with state law and under a doctor’s supervision. 
The revision ought to provide a general rule similar to the first 
sentence of the current definition.  The definition then ought to enu-
merate exceptions to that general rule.  The revised definition could 
read as follows: 
 
The term “illegal use of drugs” means the use of drugs, 
the possession or distribution of which is unlawful un-
der the Controlled Substances Act.  However, the fol-
lowing are excluded from the term “illegal use of 
drugs”: (1) uses authorized by the Controlled Sub-
stances Act; (2) uses authorized by other provisions of 
federal law; (3) uses authorized by state law and su-
pervised by a licensed health care professional.   
 
This would provide much-needed protection for disabled employees 
and job-seekers who rely on medical marijuana for treatment.  
The proposed change would clearly demonstrate that the ADA 
drug provision does not simply mirror the CSA.  It would reinforce 
that the purpose of the ADA is to protect the rights of disabled indi-
viduals, and not to serve as an enforcement arm of federal criminal 
law.  People like Joseph Casias and Jane Roe might be taking their 
chances with regard to federal drug prosecution, but at least they 
would gain the opportunity to prove that they were subjected to un-
lawful discrimination.  The proposed change does not guarantee vic-
tory for medical marijuana users; it simply affords disabled individu-
als for whom medical marijuana is an effective treatment the same 
rights that other disabled individuals have.   
  
 137 James v. City of Costa Mesa, No. SACV 10-0402 AG (MLGx), 2010 WL 
1848157, at *1 (C.D. Cal. Apr. 30, 2010). 
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B. CSA Rescheduling 
Unfortunately, revising the ADA will not protect medical mari-
juana users against possible federal criminal prosecution, and it leaves 
the ADA and CSA with conflicting messages.  Disabled persons who 
are protected by the ADA in the workplace should not have to fear 
becoming a casualty of the war on drugs.  Senator Helms feared that 
the war on drugs would be lost unless drug users were excluded from 
ADA protection.138  Unfortunately, the war on drugs has now put dis-
abled individuals at risk.  Currently, marijuana is in the most highly 
restricted category of controlled substances.139  Changing that status 
would further protect disabled individuals and harmonize the impacts 
of the ADA and the CSA. 
 
1. Scheduling Criteria 
Congress states in the findings and declarations of the CSA that 
“[m]any of the drugs included within this subchapter have a useful 
and legitimate medical purpose and are necessary to maintain the 
health and general welfare of the American people.”140  Increasingly, 
marijuana fits that description.  However, it is currently a Schedule I 
drug, and no medical use is permitted under the CSA.141  Controlled 
substances are organized into five schedules, Schedule I being the 
most severely restricted.  Schedule I substances require the following 
findings: “(A) The drug or other substance has a high potential for 
abuse.  (B) The drug or other substance has no currently accepted 
medical use in treatment in the United States.  (C) There is a lack of 
accepted safety for use of the drug or other substance under medical 
supervision.”142 
Current research regarding medical marijuana,143 coupled with the 
fact that approximately 270,000 Americans are currently using medi-
  
 138 See supra notes 90-91 and accompanying text. 
 139 21 U.S.C. § 812(c)(c)(10) (2006); 21 C.F.R. § 1308.11 (2011). 
 140 21 U.S.C. § 801(1) (2006). 
 141 Id. § 812(c)(c)(10); see also 21 C.F.R. § 1308.11 (2011); The CSA did 
create a program that has allowed a handful of individuals over the years to use medi-
cal marijuana for research purposes.  Gonzales v. Raich, 545 U.S. 1, 14 (2005) (“By 
classifying marijuana as a Schedule I drug, as opposed to listing it on a lesser sched-
ule, the manufacture, distribution, or possession of marijuana became a criminal 
offense, with the sole exception being use of the drug as part of a Food and Drug 
Administration preapproved research study.”).    
 142 § 812(b)(1)(A)-(C). 
 143 See supra Part I.A-B. 
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cal marijuana,144 indicates that marijuana’s Schedule I status is inap-
propriate.  With further study, marijuana could prove to be effective 
for a wide range of ailments.  There are side effects, just as there are 
with any prescription drug, but not to the point where it is unsafe 
when used under proper supervision.  There are other drugs which 
present a greater risk of dependence and abuse than marijuana, such as 
cocaine and methamphetamine,145 but those drugs have not been rele-
gated to Schedule I.146     
Marijuana would be more appropriately categorized as a Schedule 
II drug, which requires the following findings:  
 
(A) The drug or other substance has a high poten-
tial for abuse.  (B) The drug or other substance has 
a currently accepted medical use in treatment in 
the United States or a currently accepted medical 
use with severe restrictions.  (C) Abuse of the drug 
or other substances may lead to severe psycho-
logical or physical dependence.”147   
 
This would reflect the known medicinal value of marijuana while ac-
knowledging the importance of proper medical supervision and ac-
cepting that more research is necessary into the side effects and possi-
ble dangers of medical marijuana use.   
The U.S. Attorney General has authority under the CSA to re-
schedule a drug if the proper findings are made.148  Prior to reschedul-
ing, the Attorney General must request a scientific and medical 
evaluation of the proposed change from the Secretary of Health and 
Human Services.  The recommendation of the Secretary is binding on 
the Attorney General.149  The statute lists eight factors for considera-
tion: (1) actual or relative potential for abuse, (2) evidence of pharma-
cological effect, (3) current scientific knowledge, (4) history and pat-
tern of abuse, (5) scope, duration, and significance of abuse, (6) risk to 
public health, (7) psychic or physiological dependence liability, and 
(8) whether the substance is an immediate precursor of a substance 
already controlled under the statute.150  Marijuana does have potential 
  
 144 See supra note 3.   
 145 David Nutt et al., Development of a Rational Scale to Assess the Harm of 
Drugs of Potential Misuse, 369 THE LANCET 1047, 1051 (2007).    
 146 21 C.F.R. § 1308.12 (2011). 
 147 21 U.S.C. § 812(b)(2)(A)-(C) (2011). 
 148 Id. § 811(a). 
 149 Id. § 811(b). 
 150 Id. § 811(c)(1)-(8). 
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for abuse.  But levels of dependence are relatively low compared to 
other drugs in both Schedule I and II.151  Current scientific knowledge 
and medical practice make clear that marijuana has significant me-
dicinal value.152  
In fact, on November 30, 2011, the governors of Washington and 
Rhode Island (where medical marijuana is legal under state law) peti-
tioned the federal government to reschedule marijuana as a Schedule 
II drug.  Governor Christine Gregoire of Washington stated that, 
“[W]e have patients who really either feel like they’re criminals or 
may be engaged in some criminal activity, and really are legitimate 
patients who want medicinal marijuana.”153  More to the point, the 
governors’ petition argued that  
 
(1) cannabis for medical purposes has a relatively 
low potential for abuse, especially in comparison 
with other Schedule II drugs; (2) the medical 
community has concluded that cannabis has ac-
cepted medical use in treatment in the United 
States; and (3) cannabis has accepted safety for 
use under medical supervision and pharmacy 
based access.154 
 
The petition pointed out that marijuana use has never resulted in a 
lethal overdose, and it is safer and has milder side effects than many 
Schedule II drugs.155  In addition, current scientific evidence shows 
marijuana to be medically effective for a variety of conditions.156  
Medical marijuana has progressed to the point that—the governors 
insist—“it can be considered to have a ‘currently accepted medical 
use’ as required by 21 U.S.C. 812(b)(2)(B).”157  As a result, marijuana 
ought to be rescheduled, so that there is a path for lawful use and 
  
 151 See supra notes 145-46.   
 152 See supra Part I.A-B.   
 153 Michael Cooper, 2 Governors Asking U.S. to Ease Rules on Marijuana to 
Allow for Its Medical Use, N.Y. TIMES (Nov. 30, 2011), 
http://www.nytimes.com/2011/12/01/us/federal-marijuana-classification-should-
change-gregoire-and-chafee-say.html. 
 154 Letter from Lincoln D. Chafee, Governor of Rhode Island & Christine O. 
Gregoire, Governor of Washington, to Michele Leonhardt, Administrator, U.S. Drug 
Enforcement Administration 2 (Nov. 30, 2011), available at 
http://www.governor.wa.gov/priorities/healthcare/petition/combined_document.pdf.    
 155 Id., Exh. B, at 7-10.   
 156 Id., Exh. B, at 10-13.   
 157 Id., Exh. B, at 16.   
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those who need it for treatment do not have to risk federal prosecu-
tion. 
 
2. The DOJ Approach 
Shortly after President Obama took office, the U.S. Department of 
Justice (DOJ) took action indicating that it acknowledged the problem 
with marijuana’s Schedule I status.   On October 19, 2009, the DOJ 
issued a memo to U.S. Attorneys to “provide[] clarification and guid-
ance” regarding medical marijuana use.158  The memo emphasized the 
Justice Department’s commitment to enforcing the CSA, and reiter-
ated the dangerous nature of illegal distribution and sale of mari-
juana.159  However, in the interest of properly utilizing “limited inves-
tigative and prosecutorial resources,” the memo also instructed U.S. 
Attorneys to “not focus federal resources in your States on individuals 
whose actions are in clear and unambiguous compliance with existing 
state laws providing for the medical use of marijuana.”160   
The DOJ memo carefully circumscribed a new, more relaxed 
standard.  U.S. Attorneys were advised to be aware of certain charac-
teristics that might indicate that marijuana was not being used pursu-
ant to state law.161  The memo enumerated the following indications 
of illegal activity:  
 
• unlawful possession or unlawful use of firearms;  
• violence;  
• sales to minors;  
• financial and marketing activities inconsistent with 
the terms, conditions, or purposes of state law, includ-
ing evidence of money laundering activity and/or fi-
nancial gains or excessive amounts of cash inconsis-
tent with purported compliance with state or local 
law;  
• amounts of marijuana inconsistent with purported 
compliance with state or local law;  
• illegal possession or sale of other controlled sub-
stances; or 
  
 158 Memorandum from David W. Ogden, Deputy Att’y Gen., U.S. Dep’t of 
Justice to Selected U.S. Att’ys, et al., Investigations and Prosecutions in States 
Authorizing the Medical Use of Marijuana 1 (Oct. 19, 2009), available at 
http://www.justice.gov/opa/documents/medical-marijuana.pdf. 
 159 Id.  
 160 Id. at 1-2.  
 161 Id. at 2. 
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• ties to other criminal enterprises.162  
 
The DOJ also reaffirmed its power to prosecute marijuana use.163  The 
guidance was not intended to legalize medical marijuana use or create 
a defense to criminal prosecution.164   
Essentially, the memo imposed something of a moratorium on 
prosecuting medical marijuana use in states that have legalized it, but 
emphasized the DOJ’s right to act contrary to that moratorium at any 
time.  While this was a move in the right direction, it obviously cre-
ated a great deal of uncertainty for those using medical marijuana.  
This deferential policy might change, and a future administration 
could prosecute actions taken now in reliance on the current policy.  
In fact, the atmosphere of uncertainty has worsened as a result of re-
cent events. 
On October 7, 2011, four U.S. Attorneys in California announced 
that they would be cracking down on medical marijuana dispensaries 
that were simply “‘[l]arge commercial operations [that] cloak their 
money-making activities in the guise of helping sick people . . . .  Our 
interest is in enforcing federal criminal law, not prosecuting seriously 
ill sick people and those who are caring for them.’”165  In theory, those 
who are legitimately in need of medical marijuana should not be af-
fected, but it may be difficult for the DOJ to appropriately draw the 
line between legitimate and nonlegitimate medical marijuana provid-
ers.  State officials have already expressed frustration with the in-
creased federal intervention and fear that legitimate activity may be 
driven underground.166  California’s Attorney General Kamala Harris 
complained that the DOJ’s newfound aggressiveness “‘has only in-
creased uncertainty about how Californians can legitimately comply 
with state law.’”167 
The DOJ seems to realize that marijuana does not belong in 
Schedule I, but it so far remains unwilling to take steps to reschedule, 
perhaps for pragmatic political considerations.  For decades now, 
most politicians and administrations have been terrified of being 
  
 162 Id..  
 163 Id. 
 164 Id. 
 165 Jennifer Medina, U.S. Attorneys in California Set Crackdown on Mari-
juana, N.Y. TIMES (Oct. 7, 2011), http://www.nytimes.com/2011/10/08/us/california-
to-crack-down-on-medical-marijuana.html.   
 166 Erik Eckholm, Medical Marijuana Industry is Unnerved by U.S. Crack-
down, N.Y. TIMES (Nov. 23, 2011), http://www.nytimes.com/2011/11/24/us/medical-
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branded as “soft on crime.”168  But, with popular support for medical 
marijuana around 75 percent, that fear seems unfounded.169  The DOJ 
has the authority to initiate a schedule change and should do so in the 
interest of complying with the statutory criteria, and providing more 
certainty and stability for disabled individuals who need medical 
marijuana. 
 
C. Policy Concerns 
The current Schedule I status of marijuana puts ADA protections 
at risk.  Disabled employees who find marijuana to be the only treat-
ment that alleviates their suffering should not be punished by the gov-
ernment.  The uncertain status of marijuana under the ADA and the 
fear of criminal liability could quite possibly have a chilling effect on 
individuals otherwise eligible to bring ADA claims related to medical 
marijuana.  Employers need to know how they should treat employees 
who use medical marijuana.  Employees need to know that they can 
pursue treatment for their disabilities without fear of losing their jobs 
or being subject to criminal sanctions.    
Opponents of medical marijuana fear that rescheduling and ADA 
protection would create a litany of public policy concerns related to 
productivity, safety, and employer liability.170  The perception is that 
employees using medical marijuana are seriously affected by it and 
therefore miss more work and make more mistakes than co-
workers.171  Employers fear negative financial consequences (due to 
employee mistakes, absenteeism, or decreased productivity) and per-
haps even reputational harm.172  One author asserts that marijuana 
users are characterized by “absenteeism, shiftlessness, or malfea-
sance.”173  Furthermore, employers would have to put up with “im-
pairment of short-term memory, attention, motor skills, reaction time, 
and the organization and integration of complex information,” not to 
  
 168 See, e.g., Albert R. Hunt, A Country of Inmates, N.Y. TIMES (Nov. 20, 
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mention “apathy, lowered motivation, and impaired cognitive per-
formance.”174 
However, the ADA is designed to manage the sorts of fears ex-
pressed above.  Employers can still fire employees for failing to do 
their jobs.  They can refuse to accommodate an employee’s treatment 
choice when it would present an undue hardship.  They can impose 
prescription drug policies that are job-related and consistent with 
business necessity.  To the extent that legitimate concerns do exist, 
there are adequate employer protections built into the ADA frame-
work.   
CONCLUSION 
Individuals with disabilities should not have to choose between 
effective treatment and gainful employment.  Medical research has 
demonstrated the effectiveness of marijuana for certain applications, 
and doctors have prescribed it in numerous circumstances.  Many 
individuals rely on marijuana to treat their disabilities.  It enables 
them to work, to care for themselves, and to be self-reliant.  These 
individuals should not be excluded from ADA protection or from the 
workplace on the basis of their treatment.  Justice Breyer succinctly 
summarized what the ADA secures for disabled individuals: 
 
The statute seeks to diminish or to eliminate the 
stereotypical thought processes, the thoughtless ac-
tions, and the hostile reactions that far too often bar 
those with disabilities from participating fully in the 
Nation’s life, including the workplace . . . .  These ob-
jectives demand unprejudiced thought and reasonable 
responsive reaction on the part of employers and fel-
low workers alike.175 
 
Medical marijuana users should not be automatically excluded from 
ADA protection.  The ADA framework is fully capable of protecting 
employers while living up to its ideal of eliminating discrimination 
against individuals with disabilities.   
 
  
 174 Id.  (quoting AMA COUNCIL ON SCIENTIFIC AFFAIRS, FEATURED REPORT: 
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